PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

THE POTENTIATION OF THE RADIOPROTECTIVE EFFICACY OF TWO MEDICAL COUNTERMEASURES, GAMMA-TOCOTRIENOL AND AMIFOSTINE, BY A COMBINATION PROPHYLACTIC MODALITY.

Mouse / Radiation

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 27542813 ↗2016Reported benefit

THE POTENTIATION OF THE RADIOPROTECTIVE EFFICACY OF TWO MEDICAL COUNTERMEASURES, GAMMA-TOCOTRIENOL AND AMIFOSTINE, BY A COMBINATION PROPHYLACTIC MODALITY.

MouseRadiationCD2F1Malen = n = 16 per survival group; n = 6 per cytokine groupSubcutaneous for both agentsGT3 25 or 50 mg/kg in 0.1 ml; amifostine 30 or 50 mg/kg in…GT3 24 hours before irradiation; amifostine approximately 30 minutes before irr…

Model: Bilateral total body cobalt-60 gamma irradiation, midline dose 9.2 Gy at 0.6 Gy/min

Both agents alone improved 30-day survival relative to vehicle (6%), and every combination group reached 100% survival. With GT3 50 mg/kg, GT3 alone gave 75%, amifostine 50 mg/kg 87.5% and amifostine 30 mg/kg 37.5%; with GT3 25 mg/kg, GT3 alone gave 50%, amifostine 30 mg/kg 44% and amifostine 50 mg…

Extraction: extract · Supplied extraction confidence: 0.93. Machine-extracted fields require source verification.